Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 25.94B | 26.24B | 28.14B | 27.29B | 25.59B |
Gross Profit | 5.37B | 3.46B | 5.18B | 4.54B | 3.85B |
EBITDA | 3.16B | 2.00B | 3.10B | 2.25B | 1.57B |
Net Income | 1.61B | 629.00M | 1.37B | 1.07B | 828.00M |
Balance Sheet | |||||
Total Assets | 19.84B | 19.18B | 19.86B | 19.41B | 18.71B |
Cash, Cash Equivalents and Short-Term Investments | 2.54B | 1.71B | 1.54B | 1.79B | 2.48B |
Total Debt | 3.72B | 3.72B | 3.90B | 4.50B | 3.16B |
Total Liabilities | 8.48B | 8.60B | 9.44B | 9.72B | 7.73B |
Stockholders Equity | 10.66B | 9.83B | 9.60B | 8.75B | 10.01B |
Cash Flow | |||||
Free Cash Flow | 1.81B | 805.00M | 826.00M | 1.04B | 1.80B |
Operating Cash Flow | 2.52B | 1.62B | 1.80B | 1.96B | 2.36B |
Investing Cash Flow | -612.00M | -663.00M | -350.00M | -409.00M | -963.00M |
Financing Cash Flow | -984.00M | -1.18B | -1.54B | -1.57B | -479.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $99.18B | 7.89 | 15.73% | 20.70% | -1.46% | 155.31% | |
71 Outperform | HK$7.08B | 36.65 | 5.15% | 1.42% | 3.95% | -42.81% | |
66 Neutral | $1.13B | 49.50 | 1.74% | 1.44% | -0.82% | ― | |
65 Neutral | $26.91B | 15.42 | -4.18% | 3.21% | 1.01% | 1.34% | |
62 Neutral | HK$8.34B | 14.05 | 5.82% | ― | 38.41% | ― | |
60 Neutral | €660.52M | 29.38 | 0.92% | ― | -8.33% | -69.38% |
WH Group Limited has announced that its board of directors will hold a meeting on August 12, 2025, to review and approve the company’s unaudited consolidated interim results for the first half of the year and to consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential returns for shareholders, impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:0288) stock is a Buy with a HK$8.80 price target. To see the full list of analyst forecasts on WH Group stock, see the HK:0288 Stock Forecast page.
WH Group Limited announced that all resolutions proposed at their Annual General Meeting on May 9, 2025, were passed. Key resolutions included the adoption of financial statements, re-election of executive directors, reappointment of Ernst & Young as auditors, and the declaration of a final dividend of HK$0.40 per share. These decisions reflect the company’s stable governance and commitment to shareholder returns, potentially strengthening its market position and investor confidence.
Henan Shuanghui Investment & Development Co., Ltd., a subsidiary of WH Group Limited, reported a decrease in its financial performance for the first quarter of 2025. The company’s external sales volume of meat products fell by 1.9%, total operating income slightly declined by 0.1% to RMB14,295 million, and net profit attributable to owners decreased by 10.6% to RMB1,137 million compared to the same period in 2024. These results reflect a challenging market environment and may impact WH Group’s overall financial outlook.
Smithfield Foods, a subsidiary of WH Group Limited, reported its unaudited financial results for the first quarter of 2025, showing a notable increase in sales and net income compared to the previous year. The report highlights a strong operational performance with a significant rise in operating profit, suggesting a positive impact on the company’s market positioning and potential benefits for stakeholders.
WH Group Limited announced its unaudited quarterly results for the first quarter of 2025, highlighting a 6% increase in revenue and a 19.4% rise in operating profit compared to the previous year. Despite a 9.2% decrease in packaged meats sales volume, pork sales volume increased by 4.4%, contributing to the overall financial growth. The company’s performance was impacted by varying hog and pork prices across different regions, with significant price increases in China and the U.S., while Europe faced challenges due to an outbreak of foot and mouth disease.